PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-487

  1. 815 Posts.
    lightbulb Created with Sketch. 62
    The comprehensive research notes on PAR align very closely amongst analyst.
    Many of these reports have been shared before so I will not post them again.
    Holding firm, I maintain my conviction on PAR, just need to get the approvals.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.